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Alcohol use disorders are persistent problems with high recidivism rates despite repeated
efforts to quit drinking. Neuroadaptations that result from alcohol exposure and that persist
during periods of abstinence represent putative molecular determinants of the propensity
to relapse. Previously we demonstrated a positive association between phosphodiesterase
10A (PDE10A) gene expression and elevations in relapse-like alcohol self-administration
in rats with a history of stress exposure. Because alcohol withdrawal is characterized
by heightened anxiety-like behavior, activation of stress-responsive brain regions and an
elevated propensity to self-administer alcohol, we hypothesized that Pde10a expression
also would be upregulated in reward- and stress-responsive brain regions during periods
of acute (8–10 h) and protracted (6 weeks) alcohol withdrawal. During acute withdrawal,
elevated Pde10a mRNA expression was found in the medial and basolateral amygdala
(BLA), as well as the infralimbic and anterior cingulate subdivisions of the medial prefrontal
cortex, relative to alcohol-naïve controls. The BLA was the only region with elevated
Pde10a mRNA expression during both acute and protracted withdrawal. In contrast to
the elevations, Pde10a mRNA levels tended to be reduced during protracted withdrawal
in the dorsal striatum, prelimbic prefrontal cortex, and medial amygdala. Together these
results implicate heightened PDE10A expression in the BLA as a lasting neuroadaptation
associated with alcohol dependence.
Keywords: alcohol or ethanol dependence, basolateral or central or medial nucleus of the amygdala, alcoholism or
alcohol use disorder, acute or protracted withdrawal or abstinence, phosphodiesterase 10A, medial prefrontal or
infralimbic or anterior cingulate cortex, dorsal striatum
INTRODUCTION
Phosphodiesterase 10A (PDE10A) is a dual-speciﬁcity phospho-
diesterase, a family of enzymes that regulates cyclic nucleotide
activity tomodulate intracellular signaling pathways (Francis et al.,
2011). PDE10A can hydrolyze both cyclic adenosine monophos-
phate (cAMP) and cyclic guanosine monophosphate (cGMP;
Fujishige et al., 1999a; Loughney et al., 1999; Soderling et al., 1999)
and is prominently expressed in the brain, particularly in the stria-
tum (Fujishige et al., 1999b; Seeger et al., 2003). Like other PDEs,
PDE10Amayplay an important role inneuronal plasticity bymod-
ulating the levels of active cAMPand cGMPavailable to participate
in intracellular signaling cascades (Kroker et al., 2012; Wieschol-
leck and Manahan-Vaughan, 2012; Zhong et al., 2012; Uthayathas
et al., 2013). Acute inhibition of PDE10A increased striatal neu-
ronal activity following cortical stimulation (Threlfell et al., 2009),
and chronic PDE10A inhibition or genetic deletion altered the
expression of several genes encoding proteins involved in neu-
rotransmission (Kleiman et al., 2011). Additionally, hippocampal
long-term potentiation increased the expression of several splice
variants of Pde10a (O’Connor et al., 2004), suggesting that altered
PDE10A levels may help subserve long-term memory formation.
Importantly, PDE10A has been implicated in both appetitive
and aversive conditioning (Piccart et al., 2011, 2013), as well as
in regulating striatal dopaminergic responses to amphetamine
(Sotty et al., 2009). Taken together, these data suggest key roles
for PDE10A in reward-related learning and neural responses to
reinforcers, including drugs of abuse.
Substance use disorders have been conceptualized as diseases of
aberrant plasticity (Kauer and Malenka, 2007) in which repeated
drug or alcohol exposure alters the hedonic set-point. In the result-
ing allostatic state, drugs, or alcohol are consumed to alleviate
or prevent aversive withdrawal symptoms rather than for posi-
tive reinforcing effects (Koob and Le Moal, 2001). The negative
emotional state that arises during acute withdrawal from alcohol
exposure includes elevations in anxiety-like behavior (Baldwin
et al., 1991; Knapp et al., 1998; Pandey et al., 1999; Valdez et al.,
2002), which subside over the ﬁrst few days after removal of
alcohol access. However, a resurgence of heightened anxiety-like
behavior (Zhao et al., 2007) and increased sensitivity to stressors
(Valdez et al., 2002; Sommer et al., 2008) have been reported in
rats during protracted periods of alcohol withdrawal, weeks or
months after the ﬁnal exposure to alcohol. Such lasting nega-
tive emotional symptoms are hypothesized to motivate relapse
(Koob and Le Moal, 2001). Accordingly, molecular neuroad-
aptations that are present during both acute and protracted
withdrawal may have key roles in the long-term propensity for
abstinent individuals to relapse (Dawson et al., 2007) and repre-
sent targets for pharmacotherapeutic development. Because the
negative emotional state of alcohol withdrawal is characterized
by reduced reward function (Schulteis et al., 1995), PDE10A is
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a candidate for withdrawal-induced neuroadaptation based on
its prominent localization in and ability to regulate neuronal
activity in reward-responsive brain regions (Threlfell et al., 2009;
Mango et al., 2014). A role for PDE10A in regulating behav-
ioral responses to stress also is supported by ﬁndings that genetic
(Siuciak et al., 2006b) or pharmacological (Siuciak et al., 2006a;
Schmidt et al., 2008; Grauer et al., 2009) reduction of PDE10A
activity in rats and mice reduces conditioned avoidance of a
shock-paired chamber.
Recently we observed a relationship between Pde10a mRNA
levels and relapse-like alcohol self-administration in rats with
a history of stress exposure (Logrip and Zorrilla, 2012). Rats
with a history of stress demonstrated elevated Pde10a expres-
sion in the basolateral amygdala (BLA) and heightened relapse-
like alcohol self-administration. Furthermore, in rats with a
stress history, Pde10a mRNA levels in the infralimbic and
prelimbic prefrontal cortices (plPFCs) correlated with greater
alcohol intake, and the prelimbic cortex showed increased
Pde10a mRNA levels vs. unstressed controls in the group
with elevated relapse-like self-administration. The data impli-
cate PDE10A as a locus for neuroadaptation that regulates
behavioral responses to stress, including elevated alcohol intake.
Therefore, in the present study we hypothesized that Pde10a
expression also would be elevated during acute and/or pro-
tracted alcohol withdrawal, periods of elevated anxiety-like
behavior (Valdez et al., 2002; Zhao et al., 2007) and heightened
alcohol intake potential (Valdez et al., 2002). In particular, we
hypothesized those changes in Pde10a expression would most
likely occur in brain nuclei involved in both reward and stress
responses.
MATERIALS AND METHODS
SUBJECTS
Adult male Wistar rats, 175–200 g upon arrival, were obtained
from Charles River Laboratories (Bar Harbor, ME, USA) and
housed three per cage upon arrival. Rats were housed in a
temperature- and humidity-controlled vivarium under a reversed
light cycle (lights on 8 pm–8 am), with food (Harlan Teklad
LM-485, Indianapolis, IN, USA) and water available ad libitum.
Procedures were approved by the Institutional Animal Care and
Use Committee of The Scripps Research Institute and conformed
to guidelines set forth in the National Institutes of Health Guide
for the Care and Use of Animals.
ALCOHOL VAPOR EXPOSURE
Rats designated for intermittent alcohol vapor exposure were
transferred to housing in alcohol vapor chambers, where they
were provided with alcohol vapor in the air supply (Gilpin
et al., 2008) for 14 h daily over 5 weeks. Daily alcohol expo-
sures were followed by a 10-h withdrawal period, yielding daily
cycles of intoxication/withdrawal. Vapor exposure levels were
regulated on a weekly basis to maintain blood alcohol levels
(BALs) between 175 and 225 mg%. Serum BALs were determined
using the Analox AM1 Alcohol Analyzer (Analox Instruments
USA Inc., Lunenberg, MA, USA), with tail blood samples col-
lected weekly during the ﬁnal 2 h of the 14-h vapor exposure
period.
TISSUE PUNCH COLLECTION
Rats were euthanized during acute (8–10 h after vapor shut-
off) or protracted (6 weeks after cessation of intermittent
vapor exposure) withdrawal via rapid decapitation under isoﬂu-
rane anesthesia. Using a wire matrix, 2 mm coronal brain
slices were obtained and immediately immersed in RNAlater
(Qiagen Inc., Valencia, CA, USA). Regions of interest were
punched on a chilled stage using 14-gage (prefrontal cor-
tex and striatal sections) and 18-gage (amygdala subdivi-
sions) blunt needles, then stored at −80◦C for subsequent
processing.
RNA EXTRACTION, REVERSE TRANSCRIPTION, AND QUANTITATIVE
PCR ANALYSIS
Ribonucleic acid samples were processed and quantiﬁed as in
(Logrip and Zorrilla, 2012). Brieﬂy, RNA was extracted with QIA-
zol (Qiagen, Inc., Valencia, CA, USA), samples were treated with
DNase I (EMDMillipore, SanDiego,CA,USA) to remove genomic
DNA contamination, and concentrations were determined using
the Quant-iT RiboGreen RNA Assay Kit (Invitrogen, Carlsbad,
CA, USA). cDNA was reverse transcribed using the Superscript
III First Strand Synthesis System (Invitrogen, Carlsbad, CA, USA)
with Oligo (dT)20 primers. Gene expression levels were assessed
by quantitative polymerase chain reaction (qPCR) using Light
Cycler 480 SYBR Green I (Roche Applied Science, Indianapolis,
IN, USA) and 0.5 μM primers per reaction (ValueGene Inc., San
Diego, CA, USA), with sequences and primer conditions as pre-
viously described (Sabino et al., 2009; Logrip and Zorrilla, 2012).
Reactions were run on a Mastercycler ep realplex4 thermal cycler
(Eppendorf North America, Hauppauge, NY, USA). Threshold
cDNA copy number was interpolated per standard curves of puri-
ﬁed PCR product, and results were analyzed via second derivative
methods. Cyclophilin A (Cyp) was used as the internal standard.
WESTERN BLOTTING
Tissue samples were homogenized in TEVP buffer [10 mM Tris
base, 5 mM sodium ﬂuoride, 1 mM sodium orthovanadate, 1 mM
ethylenediaminetetraacetic acid, 1 mM ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid, pH 7.4] containing
320mM sucrose and cOmplete Protease Inhibitor Cocktail (Roche
Diagnostics Corporation, Indianapoils, IN, USA) using a rotor-
stator homogenizer (Tissue Tearor, Cole-Parmer Instrument Co.,
Vernon Hills, IL, USA). A centrifugal fractionation procedure
was utilized to enrich postsynaptic density-containingmembranes
according to the method of (Hallett et al., 2008). Protein samples
obtained pre-fractionation (total lysate, 3 μg) and the fraction
obtained after hypoosmotic lysis in TEVP buffer with 36 mM
sucrose and subsequent 21,000 × g centrifugation (postsynap-
tic density-enriched membrane fraction, BLA: ∼4 μg, striatum:
5μg)were subjected topolyacrylamide gel electrophoresis (4–15%
Tris-HCl Ready Gel, Bio-rad Laboratories, Inc., Hercules, CA,
USA, or 4–12% Invitrogen BOLT Bis-Tris Plus gels, Life Tech-
nologies, Grand Island, NY, USA). Proteins were transferred to
PVDF membranes (Immobilon-P, EMD Millipore, Billerica, MA,
USA) using standard Western blotting techniques and blocked
in 5% Blotting-Grade Blocker (Bio-rad) in Tris-buffered saline
containing 0.1% Tween-20 (Sigma-Aldrich, Inc., St. Louis, MO,
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USA) prior to incubation in rabbit anti-PDE10A or mouse
anti-β-actin primary antibodies [Sigma-Aldrich; SAB2700582,
1:250 (BLA) or 1:500 (striatum); A2228, 1:25,000]. Follow-
ing incubation in HRP-conjugated secondary antibodies [goat
anti-mouse (Bio-rad, 1706516, 1:25,000) and donkey anti-rabbit
(EMD Millipore, AP182PMI, 1:15,000)], proteins were visual-
ized via enhanced chemiluminescence (SuperSignal West Pico,
Thermo Scientiﬁc Pierce, Pittsburgh, PA, USA) and exposure
to Hy-Blot CL ﬁlm (Denville Scientiﬁc, South Plainﬁeld, NJ,
USA). Digital images were acquired using light transmission scan-
ning on the Scanjet G4050 (Hewlett-Packard Company, Palo
Alto, CA, USA) and band intensity quantiﬁed using ImageJ
software (National Institutes of Health, Bethesda, MD, USA;
Schneider et al., 2012).
STATISTICAL ANALYSIS
Quantitative polymerase chain reaction data were normalized
using z-scores and analyzed by ANCOVA with Cyp expres-
sion levels controlled as a covariate. Because skewing by out-
liers can generate false positive results with ANCOVA analysis,
two criteria were applied to identify outliers causing signiﬁcant
alteration in the results. First, any samples with Cyp values
more than 3 standard deviations from the mean of all sam-
ples were excluded (Pukelsheim, 1994), and similarity of Cyp
values between treatment groups was conﬁrmed by Student’s
t-test (p > 0.1). Second, any data causing excessive skew of
the regression, deﬁned as observations with studentized residu-
als greater than 3 for which also either the Cook’s D exceeded
the value required to yield p < 0.50 (Cook, 1977) or the lever-
age was more than twice the treatment mean, were excluded
from the analysis (Belsley et al., 1980). The collective outlier
criteria resulted in exclusion of 5.9% of all samples. Statistical
analyses were performed using Systat 12.0 (Chicago, IL, USA).
Bonferroni-corrected post hoc pairwise comparisons of ANCOVA-
generated least squares means were performed by Graph-
Pad QuickCalcs (http://graphpad.com/quickcalcs/posttest1.cfm)
as needed.
RESULTS
MEDIAL PREFRONTAL CORTEX Pde10a mRNA IS DIFFERENTIALLY
ALTERED DURING ACUTE vs. PROTRACTED WITHDRAWAL
Rats withdrawn from chronic intermittent alcohol vapor exposure
showed subregion-speciﬁc alterations in Pde10a mRNA expres-
sion in the medial prefrontal cortex (mPFC; Figure 1). As shown
in Figure 1A, Pde10a mRNA levels were signiﬁcantly elevated in
the infralimbic (ilPFC; F1,18 = 10.84, p < 0.005) and anterior cin-
gulate (ACC; F1,20 = 6.89, p < 0.05) subdivisions of the mPFC
during acute alcohol withdrawal. However, these alterations in
Pde10a mRNA levels did not persist into protracted withdrawal
(Figure 1B), as neither ilPFC (F1,16 = 0.05, p = 0.82) nor ACC
(F1,18 = 0.52, p = 0.48) Pde10a expression levels differed from
alcohol-naïve controls at the later withdrawal time point. Con-
versely, no signiﬁcant alteration in Pde10a levels was seen in the
plPFC during acute withdrawal (Figure 1A; F1,21 = 0.84, p =
0.37), whereas a trend toward reduced expression in the plPFC
was found during protracted withdrawal (Figure 1B; F1,19 = 3.41,
p = 0.08).
FIGURE 1 | Acute and protracted alcohol withdrawal differentially
impacted Pde10a mRNA expression in the medial prefrontal cortex.
(A) Acute (8–10 h) withdrawal from intermittent alcohol vapor (black bars)
exposure signiﬁcantly increased Pde10a mRNA levels in the infralimbic
(ilPFC) and anterior cingulate (ACC), but not prelimbic (plPFC), subdivisions
of the medial prefrontal cortex, relative to alcohol-naïve control rats (white
bars). (B) During protracted withdrawal, 6 weeks after the last alcohol vapor
exposure, Pde10a mRNA expression tended to be decreased in the plPFC
but was not signiﬁcantly altered in the ilPFC or ACC. Data are presented as
least squares means ± standard error of z -score transformed Pde10a
covaried for Cyp expression levels. *p < 0.05 vs. Control; n = 9–12 per
group.
UPREGULATED AMYGDALA Pde10a mRNA PERSISTS IN THE
BASOLATERAL NUCLEUS OF THE AMYGDALA
Increased Pde10a expression was observed throughout the amyg-
dala during acute withdrawal (Figure 2A), with signiﬁcant ele-
vations seen in the basolateral (BLA; F1,20 = 4.85, p < 0.05)
and medial (MeA; F1,17 = 7.90, p < 0.05) nuclei, and a trend
for an increase seen in the central nucleus (CeA; F1,19 = 4.27,
p = 0.053). During protracted withdrawal, Pde10a mRNA was
still elevated in the BLA (Figure 2B; F1,19 = 4.74, p < 0.05) but
not the CeA (F1,16 = 0.02, p = 0.89), whereas a slight trend toward
decreased Pde10a expression was seen in the MeA (F1,20 = 2.99,
p = 0.099).
ALCOHOL WITHDRAWAL DOES NOT ACUTELY MODIFY STRIATAL OR
SEPTAL Pde10a EXPRESSION
Despite, or perhaps due to, the striatum displaying the high-
est neuronal expression of PDE10A (Seeger et al., 2003), no
signiﬁcant changes in Pde10a mRNA levels were observed in
the dorsal striatum (DS) or nucleus accumbens (NAc) during
acute withdrawal (Figure 3A, F’s < 0.37, p’s > 0.55). Dur-
ing protracted alcohol withdrawal (Figure 3B), Pde10a mRNA
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FIGURE 2 | Acute and protracted alcohol withdrawal generated lasting
increases in Pde10a mRNA expression in the basolateral amygdala,
but opposite profiles in the medial amygdala. (A) Acute (8–10 h)
withdrawal from intermittent alcohol vapor (black bars) exposure
signiﬁcantly increased Pde10a mRNA levels in the basolateral (BLA) and
medial (MeA) nuclei of the amygdala, without signiﬁcant alteration in the
central nucleus (CeA), relative to alcohol-naïve control rats (white bars). (B)
Pde10a mRNA levels remained elevated in the BLA 6 weeks later, during
protracted withdrawal, while expression levels tended to be decreased in
the MeA. No signiﬁcant difference between control and alcohol-withdrawn
rats was observed in the CeA. Data are presented as least squares
means ± standard error of z -score transformed Pde10a, covaried for Cyp
expression levels. *p < 0.05 vs. Control; n = 8–12 per group.
expression tended to be reduced in the DS (F1,20 = 4.09,
p = 0.057) but not NAc (F1,19 = 0.29, p = 0.60). The neigh-
boring lateral septum (LS), a brain region previously shown to
be activated during alcohol withdrawal (Knapp et al., 1998; Kozell
et al., 2005), displayed no signiﬁcant alterations in Pde10a mRNA
expression during acute (Figure 3A, F1,21 = 1.58, p = 0.22)
or protracted (Figure 3B, F1,19 = 0.38, p = 0.55) alcohol
withdrawal.
RELATIVE Pde10a mRNA EXPRESSION AMONG TESTED BRAIN
REGIONS
Comparison of regional Pde10a expression (Figure 4A) via
qPCR in samples obtained from controls demonstrated signif-
icant regional differences (F8,192 = 50.42, p < 0.001), con-
ﬁrming the marked striatal Pde10a mRNA enrichment pre-
viously reported (Fujishige et al., 1999b; Kelly et al., 2014)
relative to all other regions tested. Of the extra-striatal
regions, the comparatively lower expression was greatest
in the infralimbic prefrontal cortex and lowest in the LS
(Figure 4A).
Consistent with the much lower levels of Pde10a mRNA
expression in the amygdala, Western blot analysis was not suf-
ﬁciently sensitive to yield adequate PDE10A protein signal at the
FIGURE 3 | Acute and protracted withdrawal did not significantly alter
Pde10a mRNA levels in striatal subregions or the neighboring lateral
septum. (A) Pde10a mRNA expression was not signiﬁcantly modiﬁed in
rats acutely (8–10 h) withdrawn from intermittent alcohol vapor (black bars),
as compared to alcohol-naïve controls (white bars), in the nucleus
accumbens, dorsal striatum, or lateral septum. (B) Pde10a mRNA levels
remained unaltered in the nucleus accumbens and lateral septum during
protracted (6 weeks) alcohol withdrawal, although levels tended to be
reduced in the dorsal striatum of alcohol-withdrawn rats. Data are
presented as least squares means ± standard error of z -score transformed
Pde10a covaried for Cyp expression levels. n = 8–12 per group.
88 kDa band for reliable quantitation in either whole tissue lysates
(Figure 4B) or in postsynaptic membrane-enriched samples
(Figure 4C) from the BLA, unlike dorsal striatal membrane-
enriched samples (Figure 4D), where PDE10A expression was
not altered during acute withdrawal, consistent with the mRNA
data. It should be noted that PDE10A protein expression was
visible in BLA immunoblots, albeit at very low levels that were
not suitable for quantitation. The quantity of protein loaded in
the present study was consistent with other fractionation studies
(Kotera et al., 2004; Fumagalli et al., 2008; Pacchioni et al., 2009).
Still, a greater protein load might have led to a different result
and could conceivably be achieved by sample pooling or other
methods of protein enrichment. Limits of extracted protein con-
centration and well volumes prevented greater loads in the present
study.
DISCUSSION
Acute and protracted withdrawal from intermittent alcohol vapor
exposure generated neuroanatomically distinct proﬁles of altered
Pde10a mRNA expression in the rat. Acute withdrawal produced
widespread elevations in Pde10a levels in stress- and reward-
responsive nuclei of the limbic system. This effect was particularly
striking in the interconnected subdivisions of the amygdala
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FIGURE 4 | Significant enrichment in striatal Pde10a expression relative
to other stress- and reward-responsive brain regions. (A) Quantitative
analysis of regional Pde10a mRNA expression in alcohol-naïve controls
demonstrated very signiﬁcantly lower Pde10a expression in medial prefrontal
and amygdala subdivisions, as compared to the striatal regions (DS, NAc). Of
the extrastriate regions assessed, infralimbic prefrontal cortex demonstrated
the highest and lateral septum the lowest levels of Pde10a mRNA in
alcohol-naïve control rats. NAc, nucleus accumbens; DS, dorsal striatum;
ilPFC, infralimbic prefrontal cortex; ACC, anterior cingulate cortex; CeA,
central amygdala; plPFC, prelimbic prefrontal cortex; MeA, medial amygdala;
BLA, basolateral amygdala; LS, lateral septum. Data are presented as least
squares means ± standard error of z -score transformed Pde10a covaried for
Cyp expression levels. *p < 0.05 vs. extrastriatal regions, $p < 0.05 vs.
lateral septum; n = 21–24 per region. (B–D) PDE10A protein levels, as
compared to β-actin expression, were assessed using Western blotting
techniques. Numbers to the left of membrane images depict the position of
molecular weight markers (in kDa), while letters beneath the lanes indicate
treatment groups (Ct, control; A, alcohol-withdrawn). (B) Lysate of protracted
withdrawal BLA samples displayed very low levels of the 88 kDa PDE10A
protein signal such that reliable quantiﬁcation was not possible. (C) A
postsynaptic density-enriched fraction from protracted withdrawal BLA also
showed minimal levels of PDE10A protein immunostaining. (D) High levels of
PDE10A protein immunostaining were observed in the dorsal striatum
postsynaptic density-enriched fraction obtained during acute withdrawal,
without signiﬁcant differences between alcohol-naïve (Control) and acutely
Alcohol Withdrawn rats. Histogram depicts the quantiﬁcation of PDE10A
protein levels normalized to β-actin, expressed as the fold change relative to
mean normalized PDE10A levels in the control group. n = 4 per group.
and mPFC (Vertes, 2004; Hoover and Vertes, 2007), as Pde10a
expression was increased in the BLA, MeA, and CeA subdivisions
of the amygdala, as well as in the ilPFC and ACC subdivisions
of the mPFC. Pde10a levels were unaltered in regions with the
highest baseline Pde10a expression, namely the DS and NAc,
as well as in the neighboring LS, though it should be noted
that high baseline striatal Pde10a expression levels may preclude
observation of small changes that would easily attain signiﬁ-
cance in brain regions with lower baseline expression. Regardless,
these data suggest that acute alcohol withdrawal may recruit
PDE10A activity in regions with otherwise low basal expres-
sion, perhaps as a compensatory mechanism to reduce heightened
neural activity observed during acute withdrawal in the amyg-
dala and mPFC (Knapp et al., 1998; Roberto et al., 2004; Lack
et al., 2007; Zhu et al., 2007; George et al., 2012; Kroener et al.,
2012).
Following an extended, 6-weeks period of abstinence, Pde10a
mRNA expression levels remained heightened only in the BLA.
Interestingly, elevated BLA Pde10a mRNA also has been seen in
rats with a history of stress and alcohol self-administration, as
compared to stress-naïve but similarly alcohol-experienced con-
trols (Logrip and Zorrilla, 2012). The collective data suggest that
stressful experiences, including repeated cycles of withdrawal from
intoxicating alcohol exposure, repeated exposure to mild foot-
shock (Logrip and Zorrilla, 2012), or their combination, may
generate long-lasting adaptations in Pde10a mRNA expression
levels. A putative behavioral function of elevated BLA PDE10A
protein levels might be to modulate stress-related behaviors
Frontiers in Integrative Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 30 | 5
Logrip and Zorrilla Pde10a expression across alcohol withdrawal
because both footshock (Kinn Rod et al., 2012) and withdrawal
from alcohol (Zhao et al., 2007; Sommer et al., 2008) can result
in heightened anxiety-like behavior for days or weeks after the
stressful experience. A previous study attributed anxiogenic-like
behavior during acute withdrawal from alcohol liquid diet to
reduced cAMP signaling in the CeA, but not BLA (Pandey et al.,
2003), an effect that could result from elevated PDE10A lev-
els. Accordingly, the present study observed a trend (p = 0.053)
for elevated CeA Pde10a mRNA levels during acute withdrawal.
In addition, however, the present study also observed lasting
increases in BLA Pde10a expression. This regional discrepancy
may result from differences in alcohol withdrawal time point (24 h
vs. 8–10 h or 6 weeks withdrawal) or in the alcohol exposure
paradigm (2 weeks continuous liquid diet vs. 5 weeks intermit-
tent alcohol vapor). Alternatively, because PDE10A can decrease
the activity of both cAMP- and cGMP-dependent signaling cas-
cades, BLA PDE10A might modulate anxiety-like behavior by
reducing cGMP activity, alone or in combination with cAMP
signaling.
Systemic inhibition of PDE10A by pharmacological (Siuciak
et al., 2006a; Schmidt et al., 2008; Grauer et al., 2009) or genetic
(Siuciak et al., 2006b)methods increases the latency to exit a shock-
paired chamber and attenuates amphetamine-induced deﬁcits in
auditory gating, further supporting a possible role for PDE10A in
modulating stress-responsive behaviors. The BLA plays a promi-
nent role in emotional memory processing (Laviolette et al., 2005;
Laviolette and Grace, 2006; Stuber et al., 2011) for both appetitive
and aversive stimuli (Dwyer, 2011), and in light of the present
data, the BLA is hypothesized to be a site of action via which
PDE10A regulates stress-related behavior, perhaps by enacting
lasting changes in BLA neuronal activity. Altered BLA activity
could produce many behavioral effects based on numerous effer-
ent projections. In addition to the CeA, the output region of the
amygdala (Pitkanen et al., 1995; Savander et al., 1995), signiﬁcant
direct BLA outputs have been demonstrated to the NAc (Russchen
andPrice, 1984;McDonald, 1991, 1992),mPFC (Krettek andPrice,
1977; McDonald, 1987, 1991, 1992), hippocampus (Pitkanen et al.,
1995; Savander et al., 1995), and bed nucleus of the stria terminalis
(Weller and Smith,1982), all regionswhichmaymodulate reward-,
withdrawal-, and stress-related behaviors. Thus, understanding
how PDE10A may participate in alcohol withdrawal-associated
BLA plasticity is of great interest for long-term adaptations in
circuit-wide reward and stress responses.
It is of particular interest to note similarities in the pro-
ﬁles of regional alteration in Pde10a mRNA expression during
acute alcohol withdrawal and those we previously reported in a
behavioral model of stress history elevation of relapse-like alco-
hol self-administration (Logrip and Zorrilla, 2012), as elevated
alcohol self-administration is observed during acute withdrawal
from intermittent alcohol vapor exposure (Rimondini et al., 2003;
O’Dell et al., 2004; Finn et al., 2007). Analysis of Pde10a expression
at the conclusion of behavioral testing demonstrated several inter-
esting relationships to parameters of alcohol self-administration:
BLA Pde10a levels positively correlated with alcohol preference
and CeA Pde10a positively correlated with alcohol intake in high
and low drinkers, respectively, during acquisition of operant
responding. Similarly, ilPFC Pde10a levels directly correlated with
the level of relapse-like alcohol self-administration in rats with
very high levels of intake, while plPFC Pde10a levels directly
correlated with relapse-like alcohol intake in rats with low base-
line levels of alcohol self-administration, the group showing
the greatest stress history-induced increase in relapse-like self-
administration. Given the elevated alcohol self-administration
and preference observed in alcohol-dependent rats (Rimondini
et al., 2003; O’Dell et al., 2004) and the increased Pde10a observed
during acute withdrawal in the BLA, CeA, and ilPFC, these data
suggest a possible role for withdrawal-induced elevations in amyg-
dala and mPFC PDE10A in generating increased alcohol intake in
alcohol-dependent rats.
PDE10A AS A MODULATOR OF NEURONAL RESPONSIVENESS
The mechanism by which withdrawal-induced PDE10A may alter
neuronal activity, thereby contributing to long-term behavioral
adaptations, remains unclear. As a negative regulator of both
cAMP and cGMP signaling (Fujishige et al., 1999a), PDE10A is
poised to regulate several intracellular signaling cascades, thereby
playing a key role in neuronal responses to stimuli. Indeed, phar-
macological inhibition of PDE10A increases the striatal response
to stimulation of cortical inputs (Threlfell et al., 2009), implicating
PDE10A as a regulator of neuronal activity. A possible long-
term mechanism for PDE10A modulation of neuronal activity
involves PKA- or PKG-dependent regulation of AMPA receptor
membrane insertion via phosphorylation of the GluA1 subunit
(Man et al., 2007; Serulle et al., 2008). PDE10A inhibitor treat-
ment increases the phosphorylation of GluA1 at serine residue 845
(Nishi et al., 2008; Grauer et al., 2009), including at the cell surface
(Grauer et al., 2009), indicating that elevated PDE10A expres-
sion may reduce GluA1 phosphorylation and thereby the synaptic
expression of GluA1-containing AMPA receptors. Genetic reduc-
tion of GluA1 phosphorylation decreases anxiety-like behavior
in rats (Kiselycznyk et al., 2013), whereas chronic alcohol expo-
sure/withdrawal increases BLAGluA1 phosphorylation (Christian
et al., 2012). Insofar as we observed elevated BLA Pde10a levels
during protracted abstinence time points associated with height-
ened anxiety-like behavior (Valdez et al., 2002; Zhao et al., 2007),
it might be argued that the elevated PDE10A expression repre-
sents a compensatory response. Alternatively, PDE10A’s net action
on neuronal responsivity in the BLA may not occur primarily via
AMPA receptor subunit GluA1 phosphorylation and membrane
insertion. Inhibition of PDE10A activity alters the phosphoryla-
tion state of other proteins besides GluA1 (Nishi et al., 2008), as
well as the expression of several neurotransmission-related genes
(Kleiman et al., 2011). Thus, PDE10A regulationof neuronal activ-
ity may also occur via an intracellular pathway, independent of the
synaptic expression of AMPA receptors. Determining the molecu-
lar consequences of elevated BLA PDE10A presents an intriguing
future endeavor.
A key unresolved question is whether the increase in BLA
PDE10A expression occurs in the predominant population of glu-
tamatergic pyramidal cells, or, instead, in the minority GABAergic
interneuron population (McDonald, 1982, 1985). For example,
if PDE10A dampens neuronal activity in the BLA as it does in
the PDE10A-rich striatum (Threlfell et al., 2009; Mango et al.,
2014), then increased PDE10A expression in BLA GABAergic
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interneurons would reduce their activity, leading to disinhibi-
tion of glutamatergic pyramidal cells and greater excitability of
BLA efferents. In contrast, increased PDE10A expression in BLA
pyramidal neurons would reduce their excitability and excita-
tory glutamatergic outﬂow. The neuroanatomical localization of
increased BLA PDE10A during withdrawal may thus yield insights
as to whether PDE10A contributes to or serves as a compensatory
response to the heightened glutamatergic synaptic transmission
that has been reported in the BLA following chronic intermit-
tent alcohol exposure (Floyd et al., 2003; Lack et al., 2007, 2009;
Christian et al., 2012, 2013).
CONCLUSION
Rats undergoing acute, but not protracted, withdrawal from alco-
hol showed widespread elevations in Pde10a mRNA expression
in interconnected mPFC and amygdala subdivisions that could
regulate the elevated self-administration observed in alcohol-
dependent rats. The persistence of elevated Pde10a in the BLA
6 weeks after the ﬁnal alcohol exposure implicates lasting changes
in BLA neuronal activity as a possible factor in the persis-
tence of relapse propensity following cessation of alcohol use.
Future investigation into the mechanisms by which PDE10A
modulates BLA activity and the role of amygdala PDE10A in reg-
ulating anxiety- and alcohol-related behaviors is of interest for
developing therapies to treat both alcohol use and stress-related
disorders.
ACKNOWLEDGMENTS
This ismanuscript number 26061 fromTheScrippsResearch Insti-
tute. The authors thank Stephanie Dela Cruz, Jeanette Helfers,
Michelle Hong, Sameeha Khalid, Nathaniel Tran, and Elizabeth
Wolf for technical assistance. Financial support was received from
the Pearson Center for Alcoholism and Addiction Research and
National Institutes of Health grantsAA06420 andAA018914, from
the National Institute on Alcohol Abuse and Alcoholism, and
DK26741, from the National Institute of Diabetes and Digestive
and Kidney Diseases. The content is solely the responsibility of
the authors and does not necessarily represent the ofﬁcial views of
the National Institutes of Health, the National Institute of Alcohol
Abuse and Alcoholism, or the National Institute of Neurological
Disorders and Stroke.
REFERENCES
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., and Britton, K. T. (1991). CRF
antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat.
Psychopharmacology (Berl.) 103, 227–232. doi: 10.1007/BF02244208
Belsley, D., Kuh, E., and Welsch, R. (1980). Regression Diagnostics: Identifying Inﬂu-
ential Data and Sources of Collinearity. Hoboken, NJ: John Wiley & Sons. doi:
10.1002/0471725153
Christian, D. T., Alexander, N. J., Diaz, M. R., and Mccool, B. A.
(2013). Thalamic glutamatergic afferents into the rat basolateral amyg-
dala exhibit increased presynaptic glutamate function following withdrawal
from chronic intermittent ethanol. Neuropharmacology 65, 134–142. doi:
10.1016/j.neuropharm.2012.09.004
Christian, D. T., Alexander, N. J., Diaz, M. R., Robinson, S., and Mccool, B. A.
(2012). Chronic intermittent ethanol and withdrawal differentially modulate
basolateral amygdala AMPA-type glutamate receptor function and trafﬁcking.
Neuropharmacology 62, 2430–2439. doi: 10.1016/j.neuropharm.2012.02.017
Cook, R. D. (1977). Detection of inﬂuential observations in linear regression.
Technometrics 19, 15–18. doi: 10.2307/1268249
Dawson, D. A., Goldstein, R. B., and Grant, B. F. (2007). Rates and correlates of
relapse among individuals in remission from DSM-IV alcohol dependence: a
3-year follow-up. Alcohol. Clin. Exp. Res. 31, 2036–2045. doi: 10.1111/j.1530-
0277.2007.00536.x
Dwyer, D. M. (2011). Lesions of the basolateral, but not central, amygdala impair
ﬂavour-taste learning based on fructose or quinine reinforcers. Behav. Brain Res.
220, 349–353. doi: 10.1016/j.bbr.2011.02.007
Finn, D. A., Snelling, C., Fretwell, A. M., Tanchuck, M. A., Underwood, L., Cole, M.,
et al. (2007). Increased drinking during withdrawal from intermittent ethanol
exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). Alcohol.
Clin. Exp. Res. 31, 939–949. doi: 10.1111/j.1530-0277.2007.00379.x
Floyd, D. W., Jung, K. Y., and Mccool, B. A. (2003). Chronic ethanol ingestion
facilitates N-methyl-D-aspartate receptor function and expression in rat lat-
eral/basolateral amygdala neurons. J. Pharmacol. Exp. Ther. 307, 1020–1029.
doi: 10.1124/jpet.103.057505
Francis, S. H., Blount, M. A., and Corbin, J. D. (2011). Mammalian cyclic nucleotide
phosphodiesterases: molecular mechanisms and physiological functions. Physiol.
Rev. 91, 651–690. doi: 10.1152/physrev.00030.2010
Fujishige, K., Kotera, J.,Michibata, H., Yuasa, K., Takebayashi, S., Okumura, K., et al.
(1999a). Cloning and characterization of a novel human phosphodiesterase that
hydrolyzes both cAMP and cGMP (PDE10A). J. Biol. Chem. 274, 18438–18445.
doi: 10.1074/jbc.274.26.18438
Fujishige, K., Kotera, J., and Omori, K. (1999b). Striatum- and testis-speciﬁc phos-
phodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur. J.
Biochem. 266, 1118–1127. doi: 10.1046/j.1432-1327.1999.00963.x
Fumagalli, F., Frasca, A., Racagni, G., and Riva, M. A. (2008). Dynamic regula-
tion of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated
administration of antipsychotic drugs. Mol. Pharmacol. 73, 1484–1490. doi:
10.1124/mol.107.043786
George, O., Sanders, C., Freiling, J., Grigoryan, E., Vu, S., Allen, C. D., et al. (2012).
Recruitment of medial prefrontal cortex neurons during alcohol withdrawal pre-
dicts cognitive impairment and excessive alcohol drinking. Proc. Natl. Acad. Sci.
U.S.A. 109, 18156–18161. doi: 10.1073/pnas.1116523109
Gilpin, N. W., Richardson, H. N., Cole, M., and Koob, G. F. (2008). Vapor
inhalation of alcohol in rats. Curr. Protoc. Neurosci. Chap. 9, Unit 9.29. doi:
10.1002/0471142301.ns0929s44
Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., et al.
(2009). Phosphodiesterase 10A inhibitor activity in preclinical models of the
positive, cognitive, and negative symptoms of schizophrenia. J. Pharmacol. Exp.
Ther. 331, 574–590. doi: 10.1124/jpet.109.155994
Hallett, P. J., Collins, T. L., Standaert, D. G., and Dunah, A. W. (2008). Bio-
chemical fractionation of brain tissue for studies of receptor distribution and
trafﬁcking. Curr. Protoc. Neurosci. Chap. 1, Unit 1.16. doi: 10.1002/0471142301.
ns0116s42
Hoover, W. B., and Vertes, R. P. (2007). Anatomical analysis of afferent projections
to the medial prefrontal cortex in the rat. Brain Struct. Funct. 212, 149–179. doi:
10.1007/s00429-007-0150-4
Kauer, J. A., and Malenka, R. C. (2007). Synaptic plasticity and addiction. Nat. Rev.
Neurosci. 8, 844–858. doi: 10.1038/nrn2234
Kelly, M. P., Adamowicz, W., Bove, S., Hartman, A. J., Mariga, A., Pathak,
G., et al. (2014). Select 3’,5’-cyclic nucleotide phosphodiesterases exhibit
altered expression in the aged rodent brain. Cell. Signal. 26, 383–397. doi:
10.1016/j.cellsig.2013.10.007
Kinn Rod, A. M., Milde, A. M., Gronli, J., Jellestad, F. K., Sundberg, H.,
and Murison, R. (2012). Long-term effects of footshock and social defeat on
anxiety-like behaviours in rats: relationships to pre-stressor plasma corticosterone
concentration. Stress 15, 658–670. doi: 10.3109/10253890.2012.663836
Kiselycznyk, C., Zhang, X., Huganir, R. L., Holmes, A., and Svenningsson,
P. (2013). Reduced phosphorylation of GluA1 subunits relates to anxiety-
like behaviours in mice. Int. J. Neuropsychopharmacol. 16, 919–924. doi:
10.1017/S1461145712001174
Kleiman, R. J., Kimmel, L. H., Bove, S. E., Lanz, T. A., Harms, J. F., Romegialli, A.,
et al. (2011). Chronic suppression of phosphodiesterase 10A alters striatal expres-
sion of genes responsible for neurotransmitter synthesis, neurotransmission, and
signaling pathways implicated in Huntington’s disease. J. Pharmacol. Exp. Ther.
336, 64–76. doi: 10.1124/jpet.110.173294
Knapp, D. J., Duncan, G. E., Crews, F. T., and Breese, G. R. (1998). Induction of
Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further
Frontiers in Integrative Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 30 | 7
Logrip and Zorrilla Pde10a expression across alcohol withdrawal
evidence for withdrawal-induced anxiety. Alcohol. Clin. Exp. Res. 22, 481–493.
doi: 10.1111/j.1530-0277.1998.tb03677.x
Koob, G. F., and Le Moal, M. (2001). Drug addiction, dysregulation of reward,
and allostasis. Neuropsychopharmacology 24, 97–129. doi: 10.1016/S0893-
133X(00)00195-0
Kotera, J., Sasaki, T., Kobayashi, T., Fujishige,K.,Yamashita,Y., andOmori,K. (2004).
Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants,
and alteration of the localization by cAMP-dependent protein kinase-dependent
phosphorylation. J. Biol. Chem. 279, 4366–4375. doi: 10.1074/jbc.M308
471200
Kozell, L. B., Hitzemann, R., and Buck, K. J. (2005). Acute alcohol withdrawal is
associated with c-Fos expression in the basal ganglia and associated circuitry:
C57BL/6J and DBA/2J inbred mouse strain analyses. Alcohol. Clin. Exp. Res. 29,
1939–1948. doi: 10.1097/01.alc.0000187592.57853.12
Krettek, J. E., and Price, J. L. (1977). Projections from the amygdaloid complex to
the cerebral cortex and thalamus in the rat and cat. J. Comp. Neurol. 172, 687–722.
doi: 10.1002/cne.901720408
Kroener, S., Mulholland, P. J., New, N. N., Gass, J. T., Becker, H. C.,
and Chandler, L. J. (2012). Chronic alcohol exposure alters behavioral and
synaptic plasticity of the rodent prefrontal cortex. PLoS ONE 7:e37541. doi:
10.1371/journal.pone.0037541
Kroker, K. S., Rast, G., Giovannini, R., Marti, A., Dorner-Ciossek, C., and Rosen-
brock, H. (2012). Inhibition of acetylcholinesterase and phosphodiesterase-9A
has differential effects on hippocampal early and late LTP. Neuropharmacology
62, 1964–1974. doi: 10.1016/j.neuropharm.2011.12.021
Lack, A. K., Christian, D. T., Diaz, M. R., and Mccool, B. A. (2009). Chronic
ethanol and withdrawal effects on kainate receptor-mediated excitatory neu-
rotransmission in the rat basolateral amygdala. Alcohol 43, 25–33. doi:
10.1016/j.alcohol.2008.11.002
Lack, A. K., Diaz, M. R., Chappell, A., Dubois, D. W., and Mccool, B. A. (2007).
Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic
function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol.
98, 3185–3196. doi: 10.1152/jn.00189.2007
Laviolette, S. R., and Grace, A. A. (2006). Cannabinoids potentiate emotional learn-
ing plasticity in neurons of the medial prefrontal cortex through basolateral
amygdala inputs. J. Neurosci. 26, 6458–6468. doi: 10.1523/JNEUROSCI.0707-
06.2006
Laviolette, S. R., Lipski,W. J., andGrace,A.A. (2005). A subpopulation of neurons in
themedial prefrontal cortex encodes emotional learningwith burst and frequency
codes through a dopamine D4 receptor-dependent basolateral amygdala input.
J. Neurosci. 25, 6066–6075. doi: 10.1523/JNEUROSCI.1168-05.2005
Logrip, M. L., and Zorrilla, E. P. (2012). Stress history increases alcohol intake
in relapse: relation to phosphodiesterase 10A. Addict. Biol. 17, 920–933. doi:
10.1111/j.1369-1600.2012.00460.x
Loughney, K., Snyder, P. B., Uher, L., Rosman, G. J., Ferguson, K., and Florio,
V. A. (1999). Isolation and characterization of PDE10A, a novel human 3’, 5’-
cyclic nucleotide phosphodiesterase. Gene 234, 109–117. doi: 10.1016/S0378-
1119(99)00171-7
Man, H. Y., Sekine-Aizawa, Y., and Huganir, R. L. (2007). Regulation of
{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafﬁck-
ing through PKA phosphorylation of the Glu receptor 1 subunit. Proc. Natl. Acad.
Sci. U.S.A. 104, 3579–3584. doi: 10.1073/pnas.0611698104
Mango, D., Bonito-Oliva, A., Ledonne, A., Nistico, R., Castelli, V., Giorgi,
M., et al. (2014). Phosphodiesterase 10A controls D1-mediated facilita-
tion of GABA release from striato-nigral projections under normal and
dopamine-depleted conditions. Neuropharmacology 76(Pt A), 127–136. doi:
10.1016/j.neuropharm.2013.08.010
McDonald, A. J. (1982). Neurons of the lateral and basolateral amygdaloid nuclei: a
Golgi study in the rat. J. Comp. Neurol. 212, 293–312. doi: 10.1002/cne.902120307
McDonald, A. J. (1985). Immunohistochemical identiﬁcation of gamma-
aminobutyric acid-containing neurons in the rat basolateral amygdala. Neurosci.
Lett. 53, 203–207. doi: 10.1016/0304-3940(85)90186-7
McDonald, A. J. (1987). Organization of amygdaloid projections to the
mediodorsal thalamus and prefrontal cortex: a ﬂuorescence retrograde trans-
port study in the rat. J. Comp. Neurol. 262, 46–58. doi: 10.1002/cne.
902620105
McDonald, A. J. (1991). Organization of amygdaloid projections to the pre-
frontal cortex and associated striatum in the rat. Neuroscience 44, 1–14. doi:
10.1016/0306-4522(91)90247-L
McDonald, A. J. (1992). Projection neurons of the basolateral amygdala: a correl-
ative Golgi and retrograde tract tracing study. Brain Res. Bull. 28, 179–185. doi:
10.1016/0361-9230(92)90177-Y
Nishi, A., Kuroiwa, M., Miller, D. B., O’Callaghan, J. P., Bateup, H. S., Shuto,
T., et al. (2008). Distinct roles of PDE4 and PDE10A in the regulation of
cAMP/PKA signaling in the striatum. J. Neurosci. 28, 10460–10471. doi:
10.1523/JNEUROSCI.2518-08.2008
O’Connor,V., Genin, A., Davis, S., Karishma, K. K., Doyere,V., De Zeeuw, C. I., et al.
(2004). Differential ampliﬁcation of intron-containing transcripts reveals long
termpotentiation-associated up-regulation of speciﬁc Pde10Aphosphodiesterase
splice variants. J. Biol. Chem. 279, 15841–15849. doi: 10.1074/jbc.M312500200
O’Dell, L. E., Roberts, A. J., Smith, R. T., and Koob, G. F. (2004).
Enhanced alcohol self-administration after intermittent versus continuous
alcohol vapor exposure. Alcohol. Clin. Exp. Res. 28, 1676–1682. doi:
10.1097/01.ALC.0000145781.11923.4E
Pacchioni, A. M., Vallone, J., Worley, P. F., and Kalivas, P. W. (2009). Neuronal
pentraxins modulate cocaine-induced neuroadaptations. J. Pharmacol. Exp. Ther.
328, 183–192. doi: 10.1124/jpet.108.143115
Pandey, S. C., Roy, A., and Zhang, H. (2003). The decreased phosphorylation
of cyclic adenosine monophosphate (cAMP) response element binding (CREB)
protein in the central amygdala acts as a molecular substrate for anxiety related
to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27, 396–409. doi:
10.1097/01.ALC.0000056616.81971.49
Pandey, S. C., Zhang, D., Mittal, N., and Nayyar, D. (1999). Potential role of the gene
transcription factor cyclic AMP-responsive element binding protein in ethanol
withdrawal-related anxiety. J. Pharmacol. Exp. Ther. 288, 866–878.
Piccart, E., Gantois, I., Laeremans, A., De Hoogt, R., Meert, T., Vanhoof, G.,
et al. (2011). Impaired appetitively as well as aversively motivated behaviors
and learning in PDE10A-deﬁcient mice suggest a role for striatal signaling
in evaluative salience attribution. Neurobiol. Learn. Mem. 95, 260–269. doi:
10.1016/j.nlm.2010.11.018
Piccart, E., Langlois, X., Vanhoof, G., and D’Hooge, R. (2013). Selective
inhibition of phosphodiesterase 10A impairs appetitive and aversive condition-
ing and incentive salience attribution. Neuropharmacology 75, 437–444. doi:
10.1016/j.neuropharm.2013.08.006
Pitkanen, A., Stefanacci, L., Farb, C. R., Go, G. G., Ledoux, J. E., and Amaral,
D. G. (1995). Intrinsic connections of the rat amygdaloid complex: projec-
tions originating in the lateral nucleus. J. Comp. Neurol. 356, 288–310. doi:
10.1002/cne.903560211
Pukelsheim, F. (1994). The three sigma rule. Am. Stat. 48, 88–91.
Rimondini, R., Sommer, W., and Heilig, M. (2003). A temporal threshold for
induction of persistent alcohol preference: behavioral evidence in a rat model
of intermittent intoxication. J. Stud. Alcohol 64, 445–449.
Roberto, M., Madamba, S. G., Stouffer, D. G., Parsons, L. H., and Siggins, G. R.
(2004). Increased GABA release in the central amygdala of ethanol-dependent
rats. J. Neurosci. 24, 10159–10166. doi: 10.1523/JNEUROSCI.3004-04.2004
Russchen, F. T., and Price, J. L. (1984). Amygdalostriatal projections in the rat. Topo-
graphical organization and ﬁber morphology shown using the lectin PHA-L as an
anterograde tracer. Neurosci. Lett. 47, 15–22. doi: 10.1016/0304-3940(84)90379-3
Sabino, V., Cottone, P., Zhao, Y., Iyer, M. R., Steardo, L. Jr., Steardo, L., et al.
(2009). The sigma-receptor antagonist BD-1063 decreases ethanol intake and
reinforcement in animal models of excessive drinking. Neuropsychopharmacology
34, 1482–1493. doi: 10.1038/npp.2008.192
Savander,V., Go, C. G., Ledoux, J. E., and Pitkanen, A. (1995). Intrinsic connections
of the rat amygdaloid complex: projections originating in the basal nucleus.
J. Comp. Neurol. 361, 345–368. doi: 10.1002/cne.903610211
Schmidt, C. J., Chapin, D. S., Cianfrogna, J., Corman, M. L., Hajos, M., Harms,
J. F., et al. (2008). Preclinical characterization of selective phosphodiesterase
10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.
J. Pharmacol. Exp. Ther. 325, 681–690. doi: 10.1124/jpet.107.132910
Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012). NIH Image to ImageJ:
25 years of image analysis. Nat. Methods 9, 671–675. doi: 10.1038/nmeth.2089
Schulteis, G., Markou, A., Cole, M., and Koob, G. F. (1995). Decreased brain reward
produced by ethanol withdrawal. Proc. Natl. Acad. Sci. U.S.A. 92, 5880–5884. doi:
10.1073/pnas.92.13.5880
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., et al.
(2003). Immunohistochemical localization of PDE10A in the rat brain. Brain Res.
985, 113–126. doi: 10.1016/S0006-8993(03)02754-9
Frontiers in Integrative Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 30 | 8
Logrip and Zorrilla Pde10a expression across alcohol withdrawal
Serulle, Y., Arancio, O., and Ziff, E. B. (2008). A role for cGMP-dependent protein
kinase II in AMPA receptor trafﬁcking and synaptic plasticity. Channels (Austin)
2, 230–232. doi: 10.4161/chan.2.4.6391
Siuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., Mccarthy, S. A., Chambers, L.,
et al. (2006a). Inhibition of the striatum-enriched phosphodiesterase PDE10A: a
novel approach to the treatment of psychosis. Neuropharmacology 51, 386–396.
doi: 10.1016/j.neuropharm.2006.04.013
Siuciak, J. A., Mccarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams,
R. D., et al. (2006b). Genetic deletion of the striatum-enriched phosphodiesterase
PDE10A: evidence for altered striatal function. Neuropharmacology 51, 374–385.
doi: 10.1016/j.neuropharm.2006.01.012
Soderling, S. H., Bayuga, S. J., and Beavo, J. A. (1999). Isolation and characterization
of a dual-substrate phosphodiesterase gene family: PDE10A. Proc. Natl. Acad. Sci.
U.S.A. 96, 7071–7076. doi: 10.1073/pnas.96.12.7071
Sommer,W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr,
C. S., et al. (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity
to stress, and amygdala crhr1 expression following a history of dependence. Biol.
Psychiatry 63, 139–145. doi: 10.1016/j.biopsych.2007.01.010
Sotty, F., Montezinho, L. P., Steiniger-Brach, B., and Nielsen, J. (2009). Phos-
phodiesterase 10A inhibition modulates the sensitivity of the mesolimbic
dopaminergic system to D-amphetamine: involvement of the D1-regulated feed-
back control of midbrain dopamine neurons. J. Neurochem. 109, 766–775. doi:
10.1111/j.1471-4159.2009.06004.x
Stuber, G. D., Sparta, D. R., Stamatakis, A. M., Van Leeuwen, W. A., Hardjopra-
jitno, J. E., Cho, S., et al. (2011). Excitatory transmission from the amygdala
to nucleus accumbens facilitates reward seeking. Nature 475, 377–380. doi:
10.1038/nature10194
Threlfell, S., Sammut, S., Menniti, F. S., Schmidt, C. J., and West, A. R. (2009).
Inhibition of phosphodiesterase 10A increases the responsiveness of striatal pro-
jection neurons to cortical stimulation. J. Pharmacol. Exp. Ther. 328, 785–795.
doi: 10.1124/jpet.108.146332
Uthayathas, S., Parameshwaran, K., Karuppagounder, S. S., Ahuja, M.,
Dhanasekaran, M., and Suppiramaniam, V. (2013). Selective inhibition of phos-
phodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice.
Synapse 67, 741–747. doi: 10.1002/syn.21676
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., et al.
(2002). Increased ethanol self-administration and anxiety-like behavior during
acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-
releasing factor. Alcohol. Clin. Exp. Res. 26, 1494–1501. doi: 10.1111/j.1530-
0277.2002.tb02448.x
Vertes, R. P. (2004). Differential projections of the infralimbic and
prelimbic cortex in the rat. Synapse 51, 32–58. doi: 10.1002/syn.
10279
Weller, K. L., and Smith, D. A. (1982). Afferent connections to the bed nucleus
of the stria terminalis. Brain Res. 232, 255–270. doi: 10.1016/0006-8993(82)
90272-4
Wiescholleck, V., and Manahan-Vaughan, D. (2012). PDE4 inhibition
enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced
impairment of long-term potentiation and object recognition memory in
an animal model of psychosis. Transl. Psychiatry 2:e89. doi: 10.1038/
tp.2012.17
Zhao, Y., Weiss, F., and Zorrilla, E. P. (2007). Remission and resurgence of
anxiety-like behavior across protracted withdrawal stages in ethanol-dependent
rats. Alcohol. Clin. Exp. Res. 31, 1505–1515. doi: 10.1111/j.1530-0277.2007.
00456.x
Zhong, P., Wang, W., Yu, F., Nazari, M., Liu, X., and Liu, Q. S. (2012). Phos-
phodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity
and conditioned place preference. Neuropsychopharmacology 37, 2377–2387. doi:
10.1038/npp.2012.93
Zhu, W., Bie, B., and Pan, Z. Z. (2007). Involvement of non-NMDA glutamate
receptors in central amygdala in synaptic actions of ethanol and ethanol-induced
reward behavior. J. Neurosci. 27, 289–298. doi: 10.1523/JNEUROSCI.3912-
06.2007
Conflict of Interest Statement:The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 23 December 2013; accepted: 18 March 2014; published online: 08 April
2014.
Citation: Logrip ML and Zorrilla EP (2014) Differential changes in amygdala and
frontal cortex Pde10a expression during acute and protracted withdrawal. Front. Integr.
Neurosci. 8:30. doi: 10.3389/fnint.2014.00030
This article was submitted to the journal Frontiers in Integrative Neuroscience.
Copyright © 2014 Logrip and Zorrilla. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Integrative Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 30 | 9
